Latest Regulatory News

Patagonia Lithium has advanced drilling at its Formentera lithium project in Argentina to 308 metres, revealing encouraging porosity and brine characteristics that suggest strong lithium potential. Six successful packer tests indicate increasing brine concentration and flow rates, with further drilling planned to deepen the resource understanding.

Hot Chili Limited has raised A$40 million through a heavily oversubscribed private placement to accelerate the development of its La Verde copper-gold discovery within the Costa Fuego project in Chile. The funding will support expanded feasibility studies, environmental approvals, and further drilling aimed at defining a higher-grade starter pit.

Micro-X has initiated installation of its first human pilot site for a portable Head CT scanner at Royal Melbourne Hospital, marking a pivotal step towards revolutionising stroke diagnosis with carbon nanotube technology.

The Federal Court of Australia has approved key restructuring schemes for Global Uranium and Enrichment Limited, paving the way for streamlined shareholder arrangements and regulatory exemptions in multiple jurisdictions.

TG Metals Limited has reported strong new drilling results from its Van Uden Gold Project, confirming increased gold continuity and extensions to its existing resource. Diamond core drilling has commenced, aiming to further expand the mineral resource estimate.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.

Bellavista Resources has successfully raised A$35 million through a two-tranche placement to fund its strategic acquisition and exploration plans in Canada and Australia.

Island Pharmaceuticals secures FDA confirmation on Galidesivir’s development under the Animal Rule, unlocking a streamlined two-stage approval process and significant commercial incentives.

DataWorks has secured a significant contract extension with iGaming Ontario, adding over C$12.5 million to its Centralised Self-Exclusion program services. This move strengthens its recurring revenue and solidifies its RegTech division’s profitability.

Celsius Resources has voluntarily suspended its shares on the ASX pending a Supreme Court ruling on the validity of its former auditor's 2011 resignation. The suspension will last until the court decision or 9 February 2026, whichever comes first.